Biodefense Market Outlook to 2023 - Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeu

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

Get Sample Copy of Report at https://www.researchformarkets.com/sample/global-biodefense-market-85976

Market Segment by Companies, this report covers: Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeutics, Dynavax Technologies,,Cleveland BioLabs Soligenix and Alnylam Pharmaceuticals.

Market Segment by Regions, regional analysis covers

· North America (USA, Canada and Mexico)
· Europe (Germany, France, UK, Russia and Italy)
· Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
· South America (Brazil, Argentina, Columbia etc.)
· Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

· Anthrax
· Smallpox
· Botulism
· Radiation/Nuclear
· Others

Market Segment by Applications, can be divided into

· US Military Market
· US Civilian Market
· Non - US Market

Browse Complete Report at https://www.researchformarkets.com/reports/global-biodefense-market-85976

Table of Content

1 Biodefense Market Overview

2 Manufacturers Profiles
2.1 Emergent Biosolutions
2.1.1 Business Overview
2.1.2 Biodefense Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Emergent Biosolutions Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Hytest
2.2.1 Business Overview
2.2.2 Biodefense Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Hytest Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Biodefense Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biodefense Market Competition, by Players

4 Global Biodefense Market Size by Regions

5 North America Biodefense Revenue by Countries

6 Europe Biodefense Revenue by Countries

7 Asia-Pacific Biodefense Revenue by Countries

8 South America Biodefense Revenue by Countries

9 Middle East and Africa Revenue Biodefense by Countries

10 Global Biodefense Market Segment by Type

11 Global Biodefense Market Segment by Application

12 Global Biodefense Market Size Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

Place Direct Purchase Order of Biodefense Market at https://www.researchformarkets.com/buy-now/global-biodefense-market-85976/one

Scope of the Report:

· This report focuses on the Biodefense in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

· USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.

· By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.

· In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.

· The worldwide market for Biodefense is expected to grow at a CAGR of roughly 8.5% over the next five years, will reach 1390 million US$ in 2023, from 850 million US$ in 2017, according to a new GIR (Global Info Research) study.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Info:
Name: Research For Markets
Email: alan.naidu@researchformarkets.com
Phone: +44 8000-4182-37

Research For Markets indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East And Africa.

Level 21, Dashwood House
69 Old Broad Street
London EC2M 1QS, United Kingdom

This release was published on openPR.